APP Abeta40, Human (Ponezumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-APP Abeta40, Human (Ponezumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityAPP Abeta40, Human (Ponezumab biosimilar)
ClonePonezumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG2 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsELISA, IP, FCM, FuncS, Neut
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human APP Abeta40 Recombinant Antibody. Ponezumab is a humanized monoclonal antibody designed for the treatment of Alzheimer's disease. Ponezumab was developed by Pfizer Inc. In November 2011 Pfizer halted the development of ponezumab after finishing a phase 2 trial. Detailed reports have to be released.
Immunogenn/a
Other NamesAnti-APP Abeta40 Recombinant Antibody, Research Grade Ponezumab, Anti-Human APP Abeta40 Recombinant Antibody, PF-04360365, RN-1219, clone 9TL, Antibody Drug Analogues, Monoclonal Antibody, YR1248, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1178862-65-1
Catalog #YR1248
Priceplease inquire
Order / More InfoAPP Abeta40, Human (Ponezumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.